{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:53:36Z","timestamp":1769097216620,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T00:00:00Z","timestamp":1457740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10198-016-0779-0","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T13:52:22Z","timestamp":1457790742000},"page":"405-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis"],"prefix":"10.1007","volume":"18","author":[{"given":"Fredrik Salvesen","family":"Haukaas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trude Margrete","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brita Askeland","family":"Winje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Aas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,12]]},"reference":[{"key":"779_CR1","unstructured":"Merck: Tuberculosis (TB). http:\/\/www.merckmanuals.com\/professional\/infectious_diseases\/mycobacteria\/tuberculosis_tb.html . (2009). Accessed 7 November 2013"},{"key":"779_CR2","unstructured":"World Health Organization: Global tuberculosis report 2015. WHO http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ (2016). Accessed 13 January 2016"},{"key":"779_CR3","doi-asserted-by":"crossref","unstructured":"Dye, C., Scheele, S., Dolin, P., Pathania, V., Raviglione, M. C., for the W. H. O. G. S., & Monitoring Project. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA. 282(7), 677\u2013686 (1999)","DOI":"10.1001\/jama.282.7.677"},{"issue":"1","key":"779_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/1756-0500-5-415","volume":"5","author":"A Dagnew","year":"2012","unstructured":"Dagnew, A., Hussein, J., Abebe, M., Zewdie, M., Mihret, A., Bedru, A., Aseffa, A.: Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth. BMC Res Notes 5(1), 415 (2012)","journal-title":"BMC Res Notes"},{"key":"779_CR5","unstructured":"Norwegian Institute of Public Health: Guide on tuberculosis. http:\/\/www.fhi.no\/eway\/default.aspx?pid=239&trg=Main_6157&Main_6157=7139:0:25,5500 (2013). Accessed 7 November 2013"},{"issue":"1","key":"779_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.0903856","volume":"185","author":"PL Lin","year":"2010","unstructured":"Lin, P.L., Flynn, J.L.: Understanding latent tuberculosis: a moving target. J. Immunol. 185(1), 15\u201322 (2010)","journal-title":"J. Immunol."},{"key":"779_CR7","volume-title":"Tuberculosis in Norway 2013\u2014with treatment results for 2012","author":"TM Arnesen","year":"2014","unstructured":"Arnesen, T.M., Eide, K.\u00c5., Norheim, G., Mengshoel, A.T., Sandbu, S., Winje, B.: Tuberculosis in Norway 2013\u2014with treatment results for 2012. Norwegian Institute of Public Health. Oslo, Norway (2014)"},{"key":"779_CR8","unstructured":"Norwegian Institute of Public Health: Countries with high occurrence of tuberculosis. http:\/\/www.fhi.no\/eway\/default.aspx?pid=240&trg=Content_6671&Main_6664=6894:0:25,7555:1:0:0:::0:0&MainContent_6894=6671:0:25,7570:1:0:0:::0:0&List_6673=6674:0:25,7574:1:0:0:::0:0&Content_6671=6683:105433::1:6682:1:::0:0 (2014). Accessed 27 August 2014"},{"key":"779_CR9","unstructured":"Regulations on tuberculosis control. https:\/\/lovdata.no\/dokument\/SF\/forskrift\/2009-02-13-205?q=forskrift+om+tuberkulosekontroll (2009). Accessed 7 July 2015"},{"key":"779_CR10","unstructured":"Norwegian Institute of Public Health: Simplified tuberculosis control. http:\/\/www.fhi.no\/artikler\/?id=110976 (2014). Accessed 2 September 2014"},{"issue":"1","key":"779_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","volume":"142","author":"R Diel","year":"2012","unstructured":"Diel, R., Loddenkemper, R., Nienhaus, A.: Predictive value of interferon-\u03b3 release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest J 142(1), 63\u201375 (2012)","journal-title":"Chest J"},{"key":"779_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1472-6963-11-247","volume":"11","author":"A Nienhaus","year":"2011","unstructured":"Nienhaus, A., Schablon, A., Costa, J.T., Diel, R.: Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res 11, 247 (2011)","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"779_CR13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40258-015-0183-4","volume":"13","author":"JR Campbell","year":"2015","unstructured":"Campbell, J.R., Sasitharan, T., Marra, F.: A systematic review of studies evaluating the cost utility of screening high-risk populations for latent tuberculosis infection. Appl Health Econ Health Policy. 13(4), 325\u2013340 (2015)","journal-title":"Appl Health Econ Health Policy"},{"key":"779_CR14","unstructured":"Haukaas, F. S.: Screening immigrants for latent tuberculosis: a cost-effectiveness analysis in a Norwegian setting. Master\u2019s thesis, University of Oslo, Oslo. http:\/\/urn.nb.no\/URN:NBN:no-44714 (2014). Accessed 7 July 2015"},{"issue":"1","key":"779_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-8-1","volume":"8","author":"B Winje","year":"2008","unstructured":"Winje, B., Oftung, F., Korsvold, G., Manns\u00e5ker, T., Jeppesen, A., Harstad, I., Heldal, E.: Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERON\u00aeTB Gold with tuberculin skin test. BMC Infect Dis 8(1), 1\u201310 (2008)","journal-title":"BMC Infect Dis"},{"issue":"1","key":"779_CR16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2458-9-141","volume":"9","author":"I Harstad","year":"2009","unstructured":"Harstad, I., Heldal, E., Steinshamn, S., Garasen, H., Jacobsen, G.: Tuberculosis screening and follow-up of asylum seekers in Norway: a cohort study. BMC Public Health 9(1), 141 (2009)","journal-title":"BMC Public Health"},{"issue":"2","key":"779_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5588\/pha.13.0011","volume":"3","author":"AIM Olsen","year":"2013","unstructured":"Olsen, A.I.M., Andersen, H.E., A\u00dfmus, J., Djupvik, J.A., Gran, G., Skaug, K., M\u00f8rkve, O.: Management of latent tuberculous infection in Norway in 2009: a descriptive cross-sectional study. Public Health Action 3(2), 166\u2013171 (2013)","journal-title":"Public Health Action"},{"key":"779_CR18","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"A Briggs","year":"2006","unstructured":"Briggs, A., Claxton, K., Sculpher, M.: Decision modelling for health economic evaluation. Oxford University Press, New York (2006)"},{"issue":"1","key":"779_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2334-10-37","volume":"10","author":"H Wiker","year":"2010","unstructured":"Wiker, H., Mustafa, T., Bjune, G., Harboe, M.: Evidence for waning of latency in a cohort study of tuberculosis. BMC Infect. Dis. 10(1), 37 (2010)","journal-title":"BMC Infect. Dis."},{"key":"779_CR20","unstructured":"The Norwegian Directorate of Health. Economic evaluation of health technologies\u2014a guide: The Norwegian Directorate of Health. https:\/\/helsedirektoratet.no\/Lists\/Publikasjoner\/Attachments\/624\/Okonomisk-evaluering-av-helsetiltak-IS-1985.pdf (2012). Accessed 11 July 2015"},{"key":"779_CR21","unstructured":"Regulations on expenses for outpatient services. http:\/\/lovdata.no\/dokument\/LTI\/forskrift\/2013-12-12-1503 (2013). Accessed 24 April 2014"},{"key":"779_CR22","unstructured":"Statistics Norway: Salary for employees in the health trusts. http:\/\/www.ssb.no\/arbeid-og-lonn\/statistikker\/lonnstasyk (2013). Accessed 30 January 2014"},{"key":"779_CR23","unstructured":"Norwegian Medical Association: Normaltariff for fastleger og legevakt 2013\u20132014. http:\/\/normaltariffen.legeforeningen.no\/pdf\/Fastlegetariff_2013.pdf (2013). Accessed 7 July 2014"},{"key":"779_CR24","unstructured":"Regulations on coverage of laboratory expenses. http:\/\/lovdata.no\/dokument\/LTI\/forskrift\/2013-12-17-1562 (2013). Accessed 24 April 2014"},{"key":"779_CR25","unstructured":"Norwegian Medicines Agency: Legemiddels\u00f8k. http:\/\/www.legemiddelverket.no\/Legemiddelsoek\/Sider\/default.aspx (2014). Accessed 17 March 2014"},{"key":"779_CR26","unstructured":"The Norwegian Directorate of Health: Innsatsstyrt finansiering 2013. http:\/\/www.helsedirektoratet.no\/publikasjoner\/innsatsstyrt-finansiering-2013\/Publikasjoner\/IS-2041_web.pdf (2012). Accessed 7 March 2014"},{"issue":"5","key":"779_CR27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1524-4733.2008.00358.x","volume":"11","author":"GR Barton","year":"2008","unstructured":"Barton, G.R., Briggs, A.H., Fenwick, E.A.L.: Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value Health 11(5), 886\u2013897 (2008)","journal-title":"Value Health"},{"issue":"3","key":"779_CR28","doi-asserted-by":"crossref","first-page":"e56044","DOI":"10.1371\/journal.pone.0056044","volume":"8","author":"O Oxlade","year":"2013","unstructured":"Oxlade, O., Pinto, M., Trajman, A., Menzies, D.: How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI. PLoS One 8(3), e56044 (2013)","journal-title":"PLoS One"},{"key":"779_CR29","doi-asserted-by":"crossref","unstructured":"Ena, J., Valls, V.: Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin. Infect. Dis. 40(5): 670\u2013676 (2005). http:\/\/cid.oxfordjournals.org\/content\/40\/5\/670.full.pdf","DOI":"10.1086\/427802"},{"key":"779_CR30","doi-asserted-by":"crossref","unstructured":"Rennie, T. W., Bothamley, G. H., Engova, D., Bates, I. P.: Patient choice promotes adherence in preventive treatment for latent tuberculosis. Eur. Respir. J. 30(4): 728\u2013735 (2007). http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17626113","DOI":"10.1183\/09031936.00034007"},{"key":"779_CR31","doi-asserted-by":"crossref","unstructured":"Spyridis, N. P., Spyridis, P. G., Gelesme, A., Sypsa, V., Valianatou, M., et al.: The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin. Infect. Dis. 45(6): 715\u2013722 (2007). http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17712755","DOI":"10.1086\/520983"},{"issue":"6","key":"779_CR32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(11)70069-X","volume":"11","author":"M Pareek","year":"2011","unstructured":"Pareek, M., Watson, J.P., Ormerod, L.P., Kon, O.M., Woltmann, G., White, P.J., Lalvani, A.: Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 11(6), 435\u2013444 (2011)","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"779_CR33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5588\/ijtld.13.0589","volume":"18","author":"CGM Erkens","year":"2014","unstructured":"Erkens, C.G.M., Dinmohamed, A.G., Kamphorst, M., Toumanian, S., van Nispen-Dobrescu, R., Alink, M., Oudshoorn, N., Mensen, M., van den Hof, S., Borgdorff, M., Verver, S.: Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands. Int. J. Tuberc. Lung Dis. 18(4), 413\u2013420 (2014)","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"779_CR34","unstructured":"Mulder, C.: Tuberculosis control among immigrants. In: Mulder, C. (ed) Factulteit der Geneeskunde (2013)"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-016-0779-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10198-016-0779-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-016-0779-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-016-0779-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:54:47Z","timestamp":1718409287000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10198-016-0779-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,12]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1007\/s10198-016-0779-0","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,12]]}}}